GlassScriptPhysician profile
Michael S Guss
NPI 1063773711
$9,353.74
in general payments reported to CMS, 2019-2025
13 companies · $1,386 in 2025
The $1,386 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,586 · 2020: $5,838 · 2022: $70.98 · 2023: $189 · 2024: $284 · 2025: $1,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,008 · Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,007.65 |
| Food and Beverage | $851.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $5,754.20 | 2020 | |
| Arthrex, INC. | $1,895.05 | 2019-2025 | |
| Kairos Surgical INC | $582.58 | 2019-2022 | |
| Banner Surgical Solutions, INC | $446.97 | 2025 | |
| Ossio INC | $167.10 | 2023 | |
| Acumed LLC | $166.06 | 2024 | Acumed, Innate Implant |
| Bioventus LLC | $133.29 | 2024-2025 | Exogen Ultrasound Bone Healing System, Supartz Fx Sodium Hyaluronate, Xcell |
| Integra Lifesciences Corporation | $83.39 | 2020 | |
| Axogen | $45.84 | 2025 | Axoguard Ha+ Nerve Protector |
| Endo Pharmaceuticals INC. | $23.08 | 2024 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $22.01 | 2023 | Exparel, Iovera |
| Stryker Corporation | $17.19 | 2025 | Alphavent, Inspace |
| Sonex Health, INC. | $16.98 | 2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Guss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.